TELA Bio, Inc. (TELA)
NASDAQ: TELA · Real-Time Price · USD
0.8140
-0.0761 (-8.55%)
At close: May 26, 2026, 4:00 PM EDT
0.8384
+0.0244 (3.00%)
After-hours: May 26, 2026, 7:55 PM EDT

TELA Bio Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
39.5450.8552.6746.7342.0243.93
Cash & Short-Term Investments
39.5450.8552.6746.7342.0243.93
Cash Growth
-7.69%-3.46%12.71%11.21%-4.35%-40.95%
Accounts Receivable
9.7210.3510.19.746.624.23
Inventory
12.2111.0212.7813.1611.797.66
Other Current Assets
2.833.372.522.12.023.23
Total Current Assets
64.375.5878.0771.7362.4559.06
Net Property, Plant & Equipment
3.63.734.083.942.911.19
Other Intangible Assets
1.261.361.742.122.52.3
Other Long-Term Assets
0.730.752.680.27--
Total Assets
69.8981.4286.5778.0567.8662.54
Accounts Payable
3.892.312.151.671.532.41
Accrued Expenses
13.9415.6713.4515.310.878.16
Total Current Liabilities
17.8317.9815.616.9712.410.58
Long-Term Debt
55.8755.6541.1240.5239.9231.49
Other Long-Term Liabilities
1.391.481.391.691.230.38
Total Long-Term Liabilities
57.2657.1342.5142.241.1531.87
Total Liabilities
75.0975.1158.1159.1753.5542.45
Common Stock
0.050.040.040.020.020.02
Additional Paid-in Capital
404.5403.74387.06339.66288.36250.06
Accumulated Other Comprehensive Income
0.090.090.090.090.15-0.05
Retained Earnings
-409.83-397.56-358.73-320.89-274.23-229.93
Shareholders' Equity
-5.26.3128.4618.8814.3120.1
Total Liabilities & Equity
69.8981.4286.5778.0567.8662.54
Total Debt
55.8755.6541.1240.5239.9231.49
Net Cash (Debt)
-16.33-4.8111.556.212.112.44
Net Cash Growth
--85.81%195.48%-83.09%-71.45%
Net Cash Per Share
-0.33-0.100.410.270.130.86
Book Value
-5.26.3128.4618.8814.3120.1
Book Value Per Share
-0.100.131.000.830.881.39
Tangible Book Value
-6.474.9526.7216.7611.8117.8
Tangible Book Value Per Share
-0.130.110.940.730.731.23
Updated May 13, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q